Keywords: synairgen, ifnb, potential, copd, drug, uk, discovery

Synairgen's IFNB as potential COPD drug

Article | 05 June 2006

Print This

The UK's Synairgen, a drug discovery firm specializing in the field of respiratory conditions, says that new data suggest that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in